GuShiio.com ① Today, Baiji Shenzhou bucked the trend and pulled up, and its share price continued to hit a record high. The increase during the year has exceeded 48%. Among them, this month’s increase is nearly 25%.
② At present, the financing balance of Baiji Shenzhou has reached 1.038 billion yuan, an increase of 689 million yuan from the end of last year, an increase of nearly twice.
③ Nearly 20 stocks hit a record high today, with Beijing Securities A-shares accounting for 40%. Looking at industries, there are more stocks in machinery and equipment, basic chemicals, and automobiles.
Financial Union, February 28 (Editor Zi Long),Today (February 28), the leading pharmaceutical stock Baiji Shenzhou bucked the trend and pulled up. As of the close, it closed up nearly 5.5% throughout the day, and its intraday increase once surged to 9%. At the same time, its share price continued to hit a record high today, and its increase during the year has exceeded 48%, of which it has risen nearly 25% since this month.
Note: Baiji Shenzhou’s share price hit a record high today (as of the close of February 28)
Hundreds of billions of pharmaceutical companies have been rising sharply, and their revenue has tripled during the year.
Yesterday evening, Baiji Shenzhou released a performance report. In 2024, revenue increased by 56.2% year-on-year, and net profit attributable to the parent company continued to lose money, but the scale narrowed compared with the same period last year. Boosted by this, Baiji Shenzhou’s share price rose again today and hit a record high during the session. As of today’s close (February 28), its annual increase has expanded to 48.06%, ranking second among the stocks with a market value of 100 billion yuan in the market, second only to Hengli Hydraulic (50.46%), and higher than popular stocks such as Weil, Sanhua Intelligent Control, Top Group, and BYD.
Note: Stocks with a market value of 100 billion yuan were among the top gainers during the year (as of the close of February 28)
From the perspective of funds, Baiji Shenzhou has received key additional positions from financiers this year. As of February 27, its current financing balance reached 1.038 billion yuan, an increase of 689 million yuan from the end of last year, an increase of nearly twice. Among them, Baiji Shenzhou’s financing balance has risen significantly since mid-February, especially on February 20, when its single-day net financing purchase reached 213 million yuan. At the same time, on February 17, February 18, and February 19, it also received more than 80 million yuan of funds from financiers in a single day.
Note: Recent changes in financing balance of Baiji Shenzhou (data as of February 27)
Looking at the entire sector, as of February 27, a total of more than 160 pharmaceutical stocks have also received additional positions from financiers during the year, accounting for nearly 44.9% of the two pharmaceutical financing targets. Among them, Baiji Shenzhou ranked first with an increase in holdings of 690 million yuan. Borui Pharmaceutical had a net purchase of nearly 330 million yuan during the year. Huahai Pharmaceutical, Dean Diagnostics, Ambi Ping, Meinian Health, Aide Biotech, etc. 10 shares also received additional positions by more than 100 million yuan from financing customers, while Kelun Pharmaceutical, Aier Ophthalmology, Jilin Aodong and other stocks ranked first in net financing sales during the year.
Note: Shares with the top 100 million yuan in net financing transactions during the year (data as of February 27)
Nearly 20 stocks hit record highs today, and nearly half of them received trading volume this week.
Today, individual stocks in the market fell more and rose less, but there were still some hot stocks that “ignited” against the market and rose to new highs. As of today’s close, excluding new shares, nearly 20 shares recorded their highest point since listing today. Among them, in addition to Baiji Shenzhou, another stock with a market value of 100 billion yuan-China Galaxy also hit a new high. However, its share price continued to fall, closing down nearly 6.5% throughout the day, and its increase during the year has narrowed to less than 10%. The four shares of Chunguang Pharmaceutical Equipment, Lintai Xincai, Lingge Technology and Sanxiang Xincai not only hit new highs but also achieved daily limits today.
Note: Individual stocks that hit record highs today (as of the close of February 28)
In terms of industries (Shenwan level), among the stocks that hit record highs today, the number of machinery and equipment, basic chemicals, and automobiles stocks is relatively large, accounting for nearly 55% of the total. They also cover electronics, pharmaceutical biology, media, non-bank finance, household appliances, building decoration, and transportation sectors. According to statistics from the securities sector, among the above-mentioned new stocks, the number of shares on the Beijing Stock Exchange is significantly larger, accounting for nearly 40%. The total share of Shanghai and Shenzhen main board stocks accounts for nearly 35%. The Science and Technology Innovation Board and GEM stocks account for nearly 15%, 10%.
In addition, based on statistics from volume and energy data, among the stocks that hit record highs today, a total of 9 stocks have recorded a new high since listing this week, accounting for nearly half of the overall proportion. Among them, 6 shares of Wanda Bearing, Tietuo Machinery, Chunguang Pharmaceutical Equipment, Lingge Technology, Hechang Juhe, and Steway recorded a historical volume today. Judging from the turnover rate data, the turnover rate of Wanda Bearing, Tietuo Machinery and Lingge Technology is relatively high today, and all are above 50%. Among them, Wanda Bearing ranked first in A-shares in terms of turnover today.
